Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.93
+0.09 (1.32%)
At close: Feb 27, 2026, 4:00 PM EST
6.85
-0.08 (-1.15%)
After-hours: Feb 27, 2026, 7:27 PM EST

Unicycive Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--0.680.95--
Revenue Growth (YoY)
---29.02%---
Gross Profit
--0.680.95--
Selling, General & Admin
19.412.18.556.572.91.01
Research & Development
12.1620.0112.912.446.081.02
Operating Expenses
31.5532.1221.45198.982.02
Operating Income
-31.55-32.12-20.77-18.05-8.98-2.02
Interest Expense
-0.06-0.07-0.08-0.01-0.63-0.24
Interest & Investment Income
0.981.260.62---
Other Non Operating Income (Expenses)
-2.77-5.8-10.3---
EBT Excluding Unusual Items
-33.41-36.73-30.54-18.06-9.61-2.26
Other Unusual Items
-----0.41-
Pretax Income
-33.41-36.73-30.54-18.06-10.02-2.26
Net Income
-33.41-36.73-30.54-18.06-10.02-2.26
Preferred Dividends & Other Adjustments
-1.10.87---
Net Income to Common
-33.41-37.82-31.41-18.06-10.02-2.26
Shares Outstanding (Basic)
1372211
Shares Outstanding (Diluted)
1372211
Shares Change (YoY)
167.35%172.97%62.98%28.96%37.37%4.68%
EPS (Basic)
-2.54-5.65-12.80-11.99-8.58-2.66
EPS (Diluted)
-2.54-5.65-12.80-11.99-8.58-2.66
Free Cash Flow
-29.88-28.65-18.3-15.65-5.8-1.46
Free Cash Flow Per Share
-2.27-4.28-7.46-10.40-4.96-1.72
Gross Margin
--100.00%100.00%--
Operating Margin
---3077.63%-1898.21%--
Profit Margin
---4653.48%-1898.84%--
Free Cash Flow Margin
---2710.37%-1645.95%--
EBITDA
-31.52-32.1-20.77-18.05-8.98-
D&A For EBITDA
0.030.020.010.010-
EBIT
-31.55-32.12-20.77-18.05-8.98-2.02
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q